CMA accuses Pfizer and Flynn of overcharging NHS for anti-epilepsy drugs

The Competition and Markets Authority (CMA) has "provisionally found" that Pfizer and Flynn Pharma overcharged the NHS for phenytoin sodium capsules after examining further evidence.